Midaform Insulin PharmFilm: Phase I data

A double-blind, dose-escalation, Swiss Phase I trial in 27 healthy volunteers showed that Midaform Insulin PharmaFilm was safe. The partners said that the product mimicked the delivery characteristics of monomeric insulin from pancreas, with a faster onset of action than subcutaneous insulin. Data were presented at the European Summit for Clinical Nanomedicine in Basel. ...